Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.
Multiple types of oncolytic viruses are currently under investigation in clinical trials. To optimize therapeutic outcomes it is believed that the plethora of different tumor types will require a diversity of different virus types. Sendai virus (SeV), a murine parainfluenza virus, displays a broad h...
Saved in:
Main Authors: | Martina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, Johanna Lampe, Irina Smirnow, Andrea Schenk, Sebastian Lange, Thomas S Weiss, Wolfgang Neubert, Ulrich M Lauer, Michael Bitzer |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/dbf8a5eb3e6e4abe89c1df655bd5ca3a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
- Oncolytic Virotherapy
-
Oncolytic Virotherapy
Published: (2016) -
Oncolytic Virotherapy: From Bench to Bedside
by: Ludi Yang, et al.
Published: (2021) -
ITC Sendai 2019 Special Issue: Part 1 – Papers from ITC Sendai 2019 –
by: Kazuo Hokkirigawa
Published: (2019) -
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
by: D. G. Roy, et al.
Published: (2021)